Advertisement
Canada markets closed
  • S&P/TSX

    22,059.03
    -184.99 (-0.83%)
     
  • S&P 500

    5,567.19
    +30.17 (+0.54%)
     
  • DOW

    39,375.87
    +67.87 (+0.17%)
     
  • CAD/USD

    0.7332
    -0.0015 (-0.20%)
     
  • CRUDE OIL

    83.44
    -0.44 (-0.52%)
     
  • Bitcoin CAD

    78,594.89
    +1,064.47 (+1.37%)
     
  • CMC Crypto 200

    1,197.84
    -10.85 (-0.90%)
     
  • GOLD FUTURES

    2,399.80
    +30.40 (+1.28%)
     
  • RUSSELL 2000

    2,026.73
    -9.90 (-0.49%)
     
  • 10-Yr Bond

    4.2720
    -0.0830 (-1.91%)
     
  • NASDAQ

    18,352.76
    +164.46 (+0.90%)
     
  • VOLATILITY

    12.48
    +0.22 (+1.79%)
     
  • FTSE

    8,203.93
    -37.33 (-0.45%)
     
  • NIKKEI 225

    40,912.37
    -1.28 (-0.00%)
     
  • CAD/EUR

    0.6762
    -0.0030 (-0.44%)
     

Novo, Lilly Tumble After Study Ties Blindness Disorder To Weight-Loss Drugs

Novo, Lilly Tumble After Study Ties Blindness Disorder To Weight-Loss Drugs

Novo Nordisk stock skidded Wednesday after a new study suggests its diabetes and weight-loss drug can lead to a blindness-causing disease.